Study Design: Early diagnosis of vertebral infection (hematogenous or postsurgical) is necessary to choose a correct therapy and to minimize dramatic complications. All patients suspected to have vertebral infection underwent radiologic imaging and 111 In-Biotin scintigraphy. Objective: Biotin is a growth factor used by many bacteria. The aim of our study is to use 111 In-Biotin to diagnose vertebral infections. Summary of Background Data: Magnetic resonance imaging, even if endowed with fairly good sensitivity and specificity, shows some limitations in the study of the onset of pathology and in postsurgical conditions. Conventional scintigraphic imaging, like bone scintigraphy with 99m Tc-MDP, 67 Ga-citrate scintigraphy, or Positron Emission Tomography with [18F]FDG, are limited by relatively low specificity; the use of Streptavidin/ 111 In-Biotin scintigraphy, based on aspecific uptake of tracer in the site of infection, shows good results in term of sensibility and specificity but the use of heterologous protein might engender immunogenic reactions. Methods: All patients (pts) (n = 110) of the study underwent 111 In-biotin scintigraphy 2 hours after intravenous injection of the tracer, 71 pts were suspected to have hematogenous vertebral infection (Group I) and 39 pts were suspected to have postsurgical infection (Group II). The reference for final diagnosis was either bacterial cultures, histopathologic analysis, and/or clinical/imaging follow-up for at least 1 year.
Results:

111
In-biotin scintigraphy showed a sensitivity of 84% and specificity of 98% in Group I and a sensitivity of 100% and specificity of 84% in Group II.
Conclusions: Our results showed that 111
In-Biotin scintigraphy possess high diagnostic accuracy. This technique is easy to perform and requires short imaging time-point after intravenous tracer injection. Moreover if 111 In-Biotin uptake is due only to high proliferation rate of bacteria presents in site of infection, it will be further investigated to discriminate definitely bacterial from sterile inflammation.
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Infections of the spine include vertebral osteomyelitis, discitiis, and spondylodiscitis (SD). SD sometimes extends to the adjacent soft tissues and it can result in meningitis, epidural, subdural, paravertebral, retropharyngeal, mediastinic, or retroperitoneal abscesses. The most frequent site of vertebral infection is the lumbar spine (45%) followed by the dorsal (35%), and cervical (20%).1 Symptoms of spine infection are sometimes nonspecific, thus delaying diagnosis by as long as 6 weeks to 7 months.1-8 The course of SD is strongly affected by howearly is diagnosis made and is effective antibiotic therapy started.8 Undiagnosed spine infection or its delayed diagnosis leads to a mortality rate as high as 11%1,8 and to a neurologic impairment in about 20% of patients.7-9 SD most frequently occurs as a consequence of direct bacterial contamination due to open-wound trauma, spine surgery, or other invasive medical procedures (spinal anesthesia, local infiltration for antalgic purposes),9-11 these conditions being defined as secondary SD. Purely hematogenous infections are instead less frequent, this condition being defined as primary SD. Pott disease is a special form of primary SD caused by Mycobacterium tuberculosis, extending frequently to paravertebral soft tissues12 and also presenting with multiorgan involvement.13,14 Back pain is the most frequent symptom in SD, followed by motor deficits and fever (usually low-grade).5,7 Blood chemistry abnormalities include moderately elevated C-reactive protein levels, erythrocyte sedimentation rate, and white blood cell count. Conditions predisposing to primary SD include drug addiction, prior implantation of vascular devices,2-6 prior severe infection at other sites and systemic metabolic diseases such as diabetes. In-biotin scintigraphy has high diagnostic accuracy in patients with various forms of osteomyelitis, including spinal infections. However, the predominant mechanism of streptavidin/ at the inflamed/infected site is related to the nonspecific accumulation of streptavidin (a 65 kDa protein) due to locally increased vascular permeability.
111
In-biotin, accumulates at the inflamed/infected focus because of its extremely high affinity for streptavidin (Kd   _ 10_15 ) and only a small fraction of 111 In-biotin, not bound to streptavidin, is directly uptaken by growing bacteria.22,23 Biotin (also called vitamin H, molecular weight 224 Da) is a growth factor for human cells and for several bacteria. In particular, pyruvate carboxylase, a key metabolic pathway for producing energy by ATP cleavage, is biotin-dependent24 and bacterial Acetyl-coA carboxylase is a biotin-dependent enzyme implied in the first step of fatty acid synthesis. 25 The potential of radiolabelled biotin as an infection-imaging agent per se has already been shown in an experimental animal model of infection using biotin labelled with fluorine-1826 as well as in a small group of patients with osteomyelitis using 111 Inbiotin.27 These considerations prompted us to explore the diagnostic potential of In-biotin alone to detect vertebral osteomyelitis in a large series of consecutive patients, in a relatively early stage of their disease.
Materials and Methods
Patients
Over a period of 4 years (2001-2004), we studied 114 consecutive patients with suspicion of spinal infection. The study was approved by our institutional review board, and informed consent was obtained from all patients. Inclusion criteria were (a) age>18 years; (b) presence of at least 2 of the following signs or symptoms: back pain, fever, radiologic findings suggesting spinal osteomyelitis, or positive bacterial culture from blood. Clinical data (including underlying condition and prior spinal surgery) and suspected site of spinal infection of the study population are given in Table 1 . In addition to 111 In-Biotin scintigraphy, all patients also underwent either magnetic resonance imaging (MRI) (n=94) or CT (n=20), as well as physical examination, routine biochemical analysis, and conventional radiograph, within 40 days after the onset of clinical signs or symptoms. Moreover, a detailed clinical history was obtained in all cases. Bacterial culture, histopathologic analysis, or clinical/imaging follow-up for at least 1 year were used as standard of reference for final diagnosis. Spinal infection was considered to be present on the basis of positive bacterial growth, characteristic findings on pathologic analysis, or in case of positive findings at clinical, laboratory, and imaging follow-up. Negative clinical/imaging signs and laboratory findings after 6 months without antibiotic therapy, as well as negative surgical findings or culture, were considered diagnostic for the absence of spinal infection. Four patients were excluded from the study because no follow-up data were available. The remaining 110 patients were divided into 2 groups on the basis of their clinical history: Group I included 71 patients with no history of prior spinal surgery, while Group II consisted of 39 patients with a history of spine surgery within 2 years before the 111 In-Biotin scan. In-chloride (111 MBq in about 1 mL) were mixed at room temperature for 15 minutes, and labeling efficiency was assessed by ascending chromatography (22, 23) ; labeling efficiency was always >98%.
Scintigraphic Imaging
Scintigraphy was performed with a dual-head _-camera (Millennium, GE Medical System, Milwaukee, WI), equipped with a medium-energy collimator, using 20% energy windows centered around the 173 and 247 keV energy peaks of 111 In (matrix 128x128 pixels, with an 1.33 electronic zoom factor). Planar and single photon emission CT (SPECT) images of the site of suspected infection were acquired 2 hours after injection of the tracer in all patients. The single imaging time-point at 2 hours postinjection of 111 In-Biotin was chosen because a previous study with streptavidin pretargeting had shown no additional diagnostic value of later acquisition times (18 -24 hours).23 Anterior and posterior planar images were acquired for 2 million counts each; the kidneys and bladder (sites of physiologic excretion) were shielded when included in the imaging field of view. SPECT images were obtained in a step-andshoot mode. The angular steps were 3° with a range of 180° per gamma camera head and a 30-second acquisit ion per step. The image matrix was 256x256 pixels, and images were reconstructed as 4.42-mm-thick sections by using an iterative algorithm. The patients suspected of having hematogenous infection underwent also total-body scan. The patients who showed definite focal uptake of 111 In-Biotin in the spine were injected intravenous with 185 MBq of 99mTc-Nanocoll at the end of the 111 In-Biotin acquisition. The images acquired 10 minutes later (without moving the patient) using a 20% energy window centered on the 140 keV energy peak of 99m Tc served to better identify the anatomic structure of the skeleton.
Image Interpretation
For the purpose of analysis, planar and SPECT images were evaluated randomly and independently by 2 experienced nuclear medicine physicians that were unaware 90 of the final diagnosis, as well as of the results of all other imaging methods. All areas with focal uptake of 111
In-Biotin in the spine higher than background were noted and were graded as positive (presence of focal uptake) or negative (no focal uptake) for spinal infection. Equivocal readings were not permitted. Independent scores of the 2 readers were compared and discrepancies were resolved by consensus. In addition to providing better topographic localization, the radiocolloid scan was also helpful for confirming spinal infection, which presents as a photopenic area at the site with abnormally high accumulation of 111 In-Biotin (28) . In-Biotin scintigraphy in terms of sensitivity, specificity, positive predictive value, negative predictive value (NPV), and accuracy in the detection of vertebral infection are reported in Table 3 , stratified for Group I and Group II, as well as for the overall patients. In Group I, In-Biotin scintigraphy was more sensitive in Group II, although at borderline of statistical significance (P=0.058). In-biotin scintigraphy shows mild tracer uptake in lumbar spine (FP) (A) corresponding on 99mTc-nanocolloids scintigraphy at L5 vertebra (B). False-positive scan of Group II, patient undergone surgery for L4-L5 disc hernia 115 days before 111In-biotin scintigraphy (C) and 99mTc-nanocolloids imaging (D)
Statistical Analysis
Data were expressed as mean values _ standard deviation, and confidence intervals (CI) whenever appropriate. Sensitivity, specificity, accuracy, positive predictive value, and NPV of 111 In-Biotin scintigraphy for the diagnosis of spinal infection were calculated for both the whole 110 patients' population and separately for Group I and for Group II. Differences between Group I and Group II were assessed by unpaireddata t test
Discussion
Diagnosing vertebral osteomyelitis early in the course of disease is crucial, considering that conventional radiology is sometimes negative within the first 4 weeks after the onset of clinical signs. Although MR imaging, especially with the fat suppression technique, is the method of choice to diagnose hematogenous vertebral infection, the diagnosis of spondylitis is not always simple. Some conditions, such as atypical site of infection, coexisting degenerative disease or myeloma-chordoma may hamper the radiologic diagnosis.16 These difficulties lead to discordant results especially in secondary SD, when discriminating true infection from the normal postoperative degenerative disc may be challenging.29 Furthermore, MR cannot always discriminate between sterile inflammation and bacterial infection.17 Moreover, while both CT and MR only allow regional visualization of the body, (whereas infection may actually be widespread), radionuclide scintigraphy offers the possibility of evaluating the whole body during a single imaging session. In-Biotin scintigraphy, proven to have superior diagnostic performance than either CT or MRI in patients with suspected spine infection.23 However, this approach raises the concerns that streptavidin, a heterologous protein, might elicit potentially dangerous immunogenic reactions in the patients undergoing such diagnostic procedure. These considerations prompted the present study based on administration of In-Biotin scintigraphy we observed an especially high proportion of true-negative results in patients of Group I (39 of 40, or 97.5%), associated however, with a certain proportion of false-negative results (5 of 31, or 16.1%). The fact that 4 out of such 5 false negative scans were observed in patients with spine infection from either Mycobacterium tuberculosis (3 cases) or Candida albicans (1 case) raises an interesting issue. In particular, tuberculous infection is typically chronic and slow-evolving, the predominant cells are lymphocytes and monocytes-macrophages, granulocytes are scanty, local vasodilatation is not pronounced, vascular permeability is only slightly altered, and endothelial activation is somewhat blunted. Furthermore, the replication rate of Mycobacterium tuberculosis is much slower than that of other bacteria,49 a feature that reduces the likelihood of biotin being actively concentrated at the infection site. On the other hand, biotin doesn't seem to be an essential growth factor for fungi, such as Candida albicans. 50 The results obtained in the present series are also consistent with a prior study in patients with spine infection undergoing 2-step Streptavidin/
111
In-Biotin scintigraphy. 23 In that study, the only 2 false-negative scans were observed in patients with tuberculous infection of the spine. As to the remaining patient with a false-negative 111 In-Biotin scan, this occurrence might be linked to the long-term antibiotic therapy administered to this patient. As to the possibility of exploring with scintigraphy the whole body, the obvious clinical advantage offered by this feature versus CT/MR imaging became apparent in 2 patients of Group I (with hematogenic infection), in whom multifocal sites of vertebral infection were observed, some of which were previously unsuspected on clinical ground. In Group I, 39 of 71 patients underwent 111 In-Biotin scintigraphy within a time range of 20 to 25 days after the onset of symptoms. Considering that scintigraphy correctly classified patients in this Group, we can conclude that 111 InBiotin scintigraphy has good diagnostic potential after 20 days from the onset of symptoms. Concerning the results obtained in patients of Group II (with suspected secondary SD), the especially high true-negative rate should be emphasized (16 of 16, or 100% NPV), while the only parameter limiting diagnostic accuracy was a non negligible rate of falsepositive scans (3 of 19, or 15.8%). Nevertheless, all such patients showed a somewhat weak focal accumulation of 111 In-Biotin at the site of prior surgery, probably reflecting a locally altered vascular permeability due to surgical trauma rather than active tracer uptake. The false positive cases of this Group had undergone surgery 32, 115, and 288 days before imaging, respectively. Considering such a prolonged time range and the fact that true positive results were observed after 26 days from surgery lead to conclude that 111 In-Biotin scintigraphy is expected to have good diagnostic potential starting from 25 days after surgery. Since 111 In-Biotin does not appreciably accumulate in normal bone and/or bone marrow, the only anatomic landmarks in the scan are the sites of physiologic excretion, such as the kidneys when exploring the low-dorsal or lumbar spine. Instead, when exploring the high-dorsal or cervical spine, exact identification of the vertebral body harboring infection can be more problematic. Thus, when no SPECT/CT equipment is available for morphofunctional coregistered imaging, performing an additional 99mTc-nanocoll scintigraphy after completion of the some limitations. Bone biopsy was not performed in all patients, and clinical/imaging follow-up data had to be used as a standard of reference in several cases introducing some potential verification bias. Moreover, selection of suspected spinal infection was based on clinical and radiologic or cultural findings and a selection bias thus may have been introduced. Nevertheless, we believe that our approach reflects daily clinical practice and, to minimize selection bias, we included patients consecutively. In conclusion, our results suggest that single-step 111 In-Biotin scintigraphy is a safe, efficient imaging modality for detecting vertebral osteomyelitis within the first 40 days after the onset of clinical symptoms. The procedure is easier to perform than the 2-step Streptavidin/ 111
In-Biotin procedure previously described with the same type of clinical application, and does not entail any potential biologic hazard as administration of a heterologous protein such as Streptavidin might entail. Still, the 1-step method described here shows high diagnostic accuracy for both in hematogenous and postsurgical vertebral infection. However, further prospective studies comparing both 111 In-Biotin scintigraphy and dynamic contrast-enhanced MRI with biopsy and culture findings in a larger series of patients are required for a more comprehensive elucidation of the diagnostic potential of this new scintigraphic tracer particularly in order to definitely discriminate bacterial infection from sterile inflammation.
Key Points •
111
In-Biotin uptake is due only to high proliferation rate of bacteria presents in site of infection.
• Single-step 111 In-Biotin scintigraphy is a safe, efficient imaging modality for detecting vertebral osteomyelitis.
•
